Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **lipopolysaccharide layer** is a structural feature unique to the **outer membrane of Gram-negative bacteria**. It consists primarily of **lipopolysaccharides (LPS)**—large amphipathic molecules composed of three main parts: 1. **Lipid A:** The hydrophobic anchor embedded in the bacterial outer membrane; responsible for most toxic effects associated with endotoxemia. 2. **Core oligosaccharide:** A short sugar chain attached directly to lipid A. 3. **O-antigen polysaccharide:** The highly variable, hydrophilic portion extending outward from the bacterium’s surface; determines serotype specificity.[1][2][4][7] The lipopolysaccharide layer serves several critical functions: - It acts as an effective permeability barrier against many antibiotics and harmful agents due to its dense packing and negative charge.[2][4] - It plays a central role in pathogenesis by activating host immune responses—particularly through recognition by innate immune receptors such as Toll-like receptor 4—which can result in fever, inflammation, septic shock, or even death if large amounts are released into circulation during severe infections.[3][6] While individual components like *lipid A* are considered molecular targets for certain drugs such as polymyxins,[general knowledge] the "lipopolysaccharide layer" itself is not typically classified as a therapeutic target like receptors or enzymes. **Note on correctness:** The term “Lipopolysaccharide layer” refers broadly to a structural feature rather than a discrete molecular entity such as an enzyme or receptor. Therefore, it is *not considered* a canonical drug target per se—it does not have gene/protein identifiers nor typical ligand-binding properties associated with pharmacological targets.[1–7]
Disruption of bacterial outer membrane integrity by binding to lipid A component of LPS, leading to increased permeability and cell death [general knowledge].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipopolysaccharide layer (LPS layer).